Aug. 9, 2023, 8:33 p.m. | Brigid Bondoc, Wendy Chow

HealthTech Magazine healthtechmagazine.net

Governance over the use of artificial intelligence in regulated environments such as healthcare has been developing in an almost arbitrary manner.
The U.S. Food and Drug Administration has taken the most definitive steps in its publication of the 2021 Artificial Intelligence and Machine Learning Software as a Medical Device Action Plan, which outlined the establishment of “practical oversight” of AI or ML-based Software as a Medical Device. However, the first draft guidance on proposing an approach to support iterative improvement …

5 questions administration artificial artificial intelligence environments food food and drug administration generative governance healthcare intelligence machine machine learning medical medical device publication questions software

More from healthtechmagazine.net / HealthTech Magazine

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Senior Principal, Product Strategy Operations, Cloud Data Analytics

@ Google | Sunnyvale, CA, USA; Austin, TX, USA

Data Scientist - HR BU

@ ServiceNow | Hyderabad, India